NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-26-006658 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 7, 2026 |
| Document Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
145,618
Total Value
$170,173.50
P&L
+inf% (+$3,328,100.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Ordinary Shares | โ | Jan 5, 2026 | Sale | 5,118 | $33.25 | $170,173.50 | 32,882 | Direct | โ | View Details | |
Chief Financial Officer | Ordinary Shares | โ | Jan 7, 2026 | Grant/Award | 25,500 | โ | โ | 58,382 | Direct | โ | View Details | |
Chief Financial Officer | Option (right to buy) | Derivative | Jan 7, 2026 | Grant/Award | 115,000 | $0.00 | $0.00 | 115,000 | Direct | โ | View Details |